Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: Broadening the clinical picture to include progressive supranuclear palsy

Brain

Volumn 127, Issue 11, 2004, Pages 2441-2451

  Paviour, D C ^a,b   Lees, A J ^a,c   Josephs, K A ^b,d   Ozawa, T ^b   Ganguly, M ^b   Strand, C ^b   Godbolt, A ^b   Howard, R S ^e   Revesz, T ^b   Holton, J L ^b  

^a Sara Koe PSP Research Centre   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d MAYO CLINIC   (United States)

^e NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Clinico pathological correlation; FTLD MND; FTLD U; Progressive supranuclear palsy

Indexed keywords

ALPHA SYNUCLEIN; LEVODOPA; TAU PROTEIN; UBIQUITIN;

ADULT; AGED; AKINESIA; ARTICLE; BRADYKINESIA; CELL INCLUSION; CLINICAL FEATURE; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL LOBAR DEGENERATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MOTOR NEURON DISEASE; MUSCLE RIGIDITY; NERVE DEGENERATION; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; TEMPORAL CORTEX;

EID: 8144227320     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh265     Document Type: Article

References (90)

1. Al Sarraj S, Maekawa S, Kibble M, Everall I, Leigh N. Ubiquitin-only intraneuronal inclusion in the substantia nigra is a characteristic feature of motor neurone disease with dementia. Neuropathol Appl Neurobiol 2002; 28: 120-8.
2. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37: 121-30.
3. Averbuch-Heller L, Helmchen C, Horn AK, Leigh RJ, Buttner-Ennever JA. Slow vertical saccades in motor neuron disease: correlation of structure and function. Ann Neurol 1998; 44: 641-8.
4. Averbuch-Heller L, Paulson GW, Daroff RB, Leigh RJ. Whipple's disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording. J Neurol Neurosurg Psychiatry 1999; 66: 532-5.
5. Bak TH, Hodges JR. Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum? J Neurol 2001; 248: 260-70.
6. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999; 8: 711-5.
7. Bergmann M, Kuchelmeister K, Migheli A, Schiffer D, Gullotta F. Motor neuron disease with pallido-luysio-nigral atrophy. Acta Neuropathol (Berl) 1993; 86: 105-8.
8. Bhidayasiri R, Riley DE, Somers JT, Lerner AJ, Buttner-Ennever JA, Leigh RJ. Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology 2001; 57: 2070-7.
9. Bigio EH, Lipton AM, White CL, Dickson DW, Hirano A. Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 2003; 29: 239-53.
10. Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, et al. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 2003; 341: 177-80.
11. Campdelacreu J, Kumru H, Tolosa E, Valls-Sole J, Benabarre A. Progressive supranuclear palsy syndrome induced by clebopride. Mov Disord 2004; 19: 482-4.
12. Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997; 41: 277-81.
13. Cooper PN, Jackson M, Lennox G, Lowe J, Mann DM. Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol 1995; 52: 1011-5.
14. Daniel SE, de Bruin VM, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995; 118: 759-70.
15. de Bruin VM, Lees AJ, Daniel SE. Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report. Mov Disord 1992; 7: 355-8.
16. de Silva R, Lashley T, Gibb G, Hanger D, Hope A, Reid A, et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 2003; 29: 288-302.
17. Dix MR, Harrison MJ, Lewis PD. Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome). A report of 9 cases with particular reference to the mechanism of the oculomotor disorder. J Neurol Sci 1971; 13: 237-56.
18. Esmonde T, Giles E, Xuereb J, Hodges J. Progressive supranuclear palsy presenting with dynamic aphasia. J Neurol Neurosurg Psychiatry 1996; 60; 403-10.
19. Fearnley JM, Revesz T, Brooks DJ, Frackowiak RS, Lees AJ. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry 1991; 54: 159-61.
20. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
21. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann Neurol 1997; 41: 706-15.
22. Gray F, Eizenbaum JF, Gherardi R, Degos JD, Poirier J. Luyso-pallido-nigral atrophy and amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 1985; 66: 78-82.
23. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord 1999; 14: 674-80.
24. Gunnarsson LG, Dahlbom K, Strandman E. Motor neuron disease and dementia reported among 13 members of a single family. Acta Neurol Scand 1991; 84: 429-33.
25. Harvey DG, Torack RM, Rosenbaum HE. Amyotrophic lateral sclerosis with ophthalmoplegia. A clinicopathologic study. Arch Neurol 1979; 36: 615-7.
26. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-9.
27. Heaton RK. Wisconsin card sorting test manual. Odessa (FL): Psychological Assessment Resources; 1981.
28. Hilton DA, McLean B. December 2001: rapidly progressive motor weakness, starting in pregnancy. Brain Pathol 2002; 12: 267-9.
29. Holton JL, Revesz T, Crooks R, Scaravilli F. Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia. Acta Neuropathol (Berl) 2002; 103: 221-7.
30. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 1981; 104: 217-47.
31. Jackson M, Lennox G, Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration 1996; 5: 339-50.
32. Josephs KA, Ishizawa T, Tsuboi Y, Cookson N, Dickson DW. A clinico-pathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy. Arch Neurol 2002; 59: 1597-601.
33. Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003; 126: 2291-303.
34. Josephs KA, Holton JL, Rossor MN, Godbolt AK, Ozawa T, Strand K, et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 2004.
35. Kawashima T, Furuta A, Doh-ura K, Kikuchi H, Iwaki T. Ubiquitin-immunoreactive skein-like inclusions in the neostriatum are not restricted to amyotrophic lateral sclerosis, but are rather aging-related structures. Acta Neuropathol (Berl) 2000; 100: 43-9.
36. Kawashima T, Doh-ura K, Kikuchi H, Iwaki T. Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum. Acta Neuropathol (Berl) 2001; 102: 467-72.
37. Kertesz A, Kawarai T, Rogaeva E, George-Hyslop P, Poorkaj P, Bird TD, et al. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 2000; 54: 818-27.
38. Knopman DS, Mastri AR, Frey WH, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 1990; 40: 251-6.
39. Komachi H, Okeda R, Ishii N, Yanagisawa K, Yamada M, Miyatake T. Motor neuron disease with dementia and ophthalmoplegia. A clinical and pathological study. J Neurol 1994; 241: 592-6.
40. Kusaka H, Matsumoto S, Imai T. Adult-onset motor neuron disease with basophilic intraneuronal inclusion bodies. Clin Neuropathol 1993; 12: 215-8.
41. Lees AJ. The Steele Richardson Olszewski syndrome. In: Marsden CD, Fahn S, editors. Movement disorders 2. London: Butterworths; 1987. p. 272-87.
42. Litvan I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl 1994; 42: 69-78.
43. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55: 97-105.
44. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48: 19-125.
45. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003; 18: 467-86.
46. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002; 59: 1077-9.
47. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003; 60: 1094-7.
48. Lowe J, Rossor M. Frontotemporal lobar degeneration. In: Dickson DW, editor. Neurodegeneration: The molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press; 2003. p. 342-8.
49. Machida Y, Tsuchiya K, Anno M, Haga C, Ito T, Shimo Y, et al. Sporadic amyotrophic lateral sclerosis with multiple system degeneration: a report of an autopsy case without respirator administration. Acta Neuropathol (Berl) 1999; 98: 512-5.
50. Mackenzie IR, Feldman H. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases. Acta Neuropathol (Berl) 2003a; 105: 543-8.
51. Mackenzie IR, Feldman H. The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease. Acta Neuropathol (Berl) 2003b; 105: 98-102.
52. Mackenzie IR, Feldman H. Extrapyramidal features in patients with motor neuron disease and dementia; a clinicopathological correlative study. Acta Neuropathol (Berl) 2004; 107: 336-40.
53. Mann DM, South PW, Snowden JS, Neary D. Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 1993; 56: 605-14.
54. McKenna P, Warrington EK. Graded naming test. Windsor (UK): NFER-Nelson; 1983.
55. Mizutani T, Sakamaki S, Tsuchiya N, Kamei S, Kohzu H, Horiuchi R, et al. Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol (Berl) 1992; 84: 372-7.
56. Morris HR, Lees AJ, Wood NW. Neurofibrillary tangle parkinsonian disorders-tau pathology and tau genetics. Mov Disord 1999; 14: 731-6.
57. Morris HR, Gibb G, Katzenschlager R, Wood NW, Hanger DP, Strand C, et al. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 2002; 125: 969-75.
58. Morris HR, Osaki Y, Holton J, Lees AJ, Wood NW, Revesz T, et al. Tau exon 10 + 16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. Neurology 2003; 61: 102-4.
59. Murialdo A, Marchese R, Abbruzzese G, Tabaton M, Michelozzi G, Schiavoni S. Neurosyphilis presenting as progressive supranuclear palsy. Mov Disord 2000; 15: 730-1.
60. Nakashima H, Terada S, Ishizu H, Tanabe Y, Yokota O, Ishihara T, et al. An autopsied case of dementia with Lewy bodies with supranuclear gaze palsy. Neurol Res 2003; 25: 533-7.
61. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
62. Nelson HE. National adult reading test (NART): test manual. Windsor (UK): NFER-Nelson; 1982.
63. Oda M, Akagawa N, Tabuchi Y, Tanabe H. A sporadic juvenile case of the amyotrophic lateral sclerosis with neuronal intracytoplasmic inclusions. Acta Neuropathol (Berl) 1978; 44: 211-6.
64. Okamoto K, Hirai S, Amari M, Iizuka T, Watanabe M, Murakami N, et al. Oculomotor nuclear pathology in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 1993; 85: 458-62.
65. Okuda B, Yamamoto T, Yamasaki M, Maya K, Imai T. Motor neuron disease with slow eye movements and vertical gaze palsy. Acta Neurol Scand 1992; 85: 71-6.
66. Qureshi AI, Wilmot G, Dihenia B, Schneider JA, Krendel DA. Motor neuron disease with parkinsonism. Arch Neurol 1996; 53: 987-91.
67. Revesz T, Daniel SE, Lees AJ, Will RG. A case of progressive subcortical gliosis associated with deposition of abnormal prion protein (PrP). J Neurol Neurosurg Psychiatry 1995; 58: 759-60.
68. Revesz T, Sangha H, Daniel SE. The nucleus raphe interpositus in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Brain 1996; 119: 1137-43.
69. Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003; 126: 2016-22.
70. Rossor MN, Revesz T, Lantos PL, Warrington EK. Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain 2000; 123: 267-76.
71. Sasaki S, Toi S, Shirata A, Yamane K, Sakuma H, Iwata M. Immunohistochemical and ultrastructural study of basophilic inclusions in adult-onset motor neuron disease. Acta Neuropathol (Berl) 2001; 102: 200-6.
72. Shallice T, Evans ME. The involvement of the frontal lobes in cognitive estimation. Cortex 1978; 14: 294-303.
73. Silbert PL, Gubbay SS, Khangure M. Multifocal astrocytoma masquerading as possible progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1993; 56: 220-1.
74. Soliveri P, Rossi G, Monza D, Tagliavini F, Piacentini S, Albanese A, et al. A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Arch Neurol 2003; 60: 1454-6.
75. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. 2nd ed. New York: Oxford University Press; 1998.
76. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964; 10: 333-59.
77. Stell R, Bronstein AM. Eye movement abnormalities in extrapyramidal diseases. In: Marsden CD, Fahn S, editors. Movement disorders 3. Oxford: Butterworth-Heinemann; 1994. p. 88-113.
78. Su M, Yoshida Y, Ishiguro H, Hirota K. Nigral degeneration in a case of amyotrophic lateral sclerosis: evidence of Lewy body-like and skein-like inclusions in the pigmented neurons. Clin Neuropathol 1999; 18: 293-300.
79. Sudo S, Fukutani Y, Matsubara R, Sasaki K, Shiozawa M, Wada Y, et al. Motor neuron disease with dementia combined with degeneration of striatonigral and pallidoluysian systems. Acta Neuropathol (Berl) 2002; 103: 521-5.
80. Verny M, Duyckaerts C, Agid Y, Hauw JJ. The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 1996; 119: 1123-36.
81. Wakabayashi K, Piao YS, Hayashi S, Kakita A, Yamada M, Takahashi H. Ubiquitinated neuronal inclusions in the neostriatum in patients with amyotrophic lateral sclerosis with and without dementia - a study of 60 patients 31 to 87 years of age. Clin Neuropathol 2001; 20: 47-52.
82. Warrington EK. Manual for the recognition memory test for words and faces. Windsor (UK): NFER-Nelson; 1984.
83. Warrington EK, James M, Maciejewski C. The WAIS as a lateralizing and localizing diagnostic instrument: a study of 656 patients with unilateral cerebral lesions. Neuropsychologia 1986; 24: 223-39.
84. Weeks RA, Scaravilli F, Lees AJ, Carroll C, Husain M, Rudge P. Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome. Mov Disord 2003; 18: 331-6.
85. Weigl E. Zur Psychologie sogenannter Abstraktionsprozesse. Z Psychol 1927; 103: 2-45.
86. Will RG, Lees AJ, Gibb W, Barnard RO. A case of progressive subcortical gliosis presenting clinically as Steele-Richardson-Olszewski syndrome. J Neurol Neurosurg Psychiatry 1988; 51: 1224-7.
87. Williams TL, Shaw PJ, Lowe J, Bates D, Ince PG. Parkinsonism in motor neuron disease: case report and literature review. Acta Neuropathol (Berl) 1995; 89: 275-83.
88. Wilson CM, Grace GM, Munoz DG, He BP, Strong MJ. Cognitive impairment in sporadic ALS: a pathologic continuum underlying a multisystem disorder. Neurology 2001; 57: 651-7.
89. Winikates J, Jankovic J. Vascular progressive supranuclear palsy. J Neural Transm Suppl 1994; 42: 189-201.
90. Yuki N, Yamada M, Yuasa T, Kaneko K, Inuzuka T, Arai M, et al. Atypical motor neuron disease with severe ophthalmoloplegia: a report of two cases. J Neurol 1995; 242: 541-6.